Related Experiment Videos
Beyond anatomy: MR imaging as a molecular diagnostic tool
1Department of Surgery, Section of Surgical Oncology and Endocrine Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599-7210, USA.
Surgical Oncology Clinics of North America
|November 21, 1998
Summary
Magnetic resonance imaging (MRI) offers advanced cellular-level diagnostics. Targeted agents and magnetic resonance spectroscopy enable precise tumor analysis and treatment response prediction.
Area of Science:
- Biomedical Imaging
- Molecular Imaging
- Medical Physics
Background:
- Magnetic resonance imaging (MRI) is evolving beyond anatomical imaging.
- Advances in cellular biology necessitate more precise diagnostic tools.
- MRI's sensitivity to physico-chemical properties offers a unique advantage.
Purpose of the Study:
- To explore the potential of MRI with targeted agents and magnetic resonance spectroscopy (MRS) for cellular-level diagnosis.
- To highlight the clinical applications of MRS in oncology.
Main Methods:
- Development of targeted imaging agents using monoclonal antibodies, liposomes, and peptides.
- Application of magnetic resonance spectroscopy for in vivo and in vitro analysis of tumor and normal tissue composition.
- Investigating the use of MRS for lesion characterization and treatment monitoring.
Main Results:
- Targeted imaging agents can be prepared to bind specific cell populations.
- MRS allows detailed chemical analysis of tumors, differentiating them from normal tissues.
- Potential clinical applications include malignancy assessment, carcinoma staging, and predicting chemotherapy response.
Conclusions:
- MRI, enhanced by targeted agents and MRS, shows significant promise for cellular-level diagnostics.
- Widespread clinical applications in oncology are anticipated in the near future.
- This technology facilitates personalized medicine through precise disease characterization and treatment guidance.